Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Open in API
Filings indexed 1,333 across all filing types
Latest filing 2010-08-19 Interim / Quarterly Rep…
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Rapport 2Q10 og 1H10.pdf (Att: 265805)
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive quarterly financial report for Photocure ASA for Q2 and the first half of 2010. It contains detailed financial tables (income statement, key figures), operational reviews, strategy updates, and clinical development progress. It is not an announcement of a report, but the report itself, containing substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report. Q2 2010
2010-08-19 Norwegian
Results 2Q10 and 1H10.pdf (Att: 265804)
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report titled 'Results for the 2nd quarter and first half year 2010' for Photocure ASA. It contains detailed financial tables (Key figures, Sales revenues, etc.), operational reviews, and strategic updates for the specified period. It is not an announcement of a report (RPA) or a simple earnings release (ER) as it provides extensive narrative analysis and detailed financial data. Therefore, it is classified as an Interim/Quarterly Report. Q2 2010
2010-08-19 English
Resultater for 2. kvartal og 1. halvår 2010
Report Publication Announcement Classification · 95% confidence The document is a short announcement (approx. 4,100 characters) titled 'Resultater for 2. kvartal og 1. halvår 2010' (Results for Q2 and 1H 2010). It provides key financial highlights and a summary table but explicitly states 'Vennligst se fullstendig rapport vedlagt' (Please see the full report attached). According to the 'Menu vs Meal' rule, since this is a short announcement of a report that is attached elsewhere, it is classified as a Report Publication Announcement (RPA).
2010-08-19 Norwegian
Results for the 2nd quarter and first half year 2010
Report Publication Announcement Classification · 95% confidence The document is titled 'Results for the 2nd quarter and first half year 2010' and provides a summary of financial highlights, key figures, and operational updates. Crucially, the text contains the sentence 'Please find the full financial report enclosed,' which indicates that this document is an announcement of the report rather than the full report itself. Given its length (under 5,000 characters) and its function as an announcement of the release of financial results, it is classified as a Report Publication Announcement (RPA).
2010-08-19 English
Invitasjon til presentasjon av resultater andre kvartal 2010
Report Publication Announcement Classification · 95% confidence The document is an invitation to a presentation of the company's second-quarter 2010 results. It provides details on the time, location, and speakers for the event, and mentions that the presentation will be available on their website. Since this is an announcement regarding the timing and release of a report/presentation rather than the report itself, it falls under the Report Publication Announcement (RPA) category.
2010-08-13 Norwegian
Photocure ASA etablerer datterselskap i USA for å utvikle sin dermatologivirksomhet
Regulatory Filings Classification · 95% confidence The document is a corporate press release announcing the establishment of a new US subsidiary (Photocure Inc) and the appointment of a new executive (Terry Conrad). It does not fit into specific categories like financial reports, proxy statements, or dividend notices. As it is a general corporate announcement required under the Norwegian Securities Trading Act (verdipapirhandelloven §5-12), it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous regulatory announcements.
2010-08-04 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.